SCHEMBL7989431

SCHEMBL7989431

C=CCCCCN(C)C(=O)[C@H](Cc1ccc(OCc2ccccc2)cc1)NC(=O)O

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 2/20 0.51
MMP8 P22894 2/20 0.51
PPARG P37231 5/20 0.49
MAOB P27338 3/20 0.45
MME P08473 1/20 0.45
ACE P12821 1/20 0.45
CPA1 P15085 1/20 0.45
ACE2 Q9BYF1 1/20 0.45
GPR34 Q9UPC5 3/20 0.44
KDM4E B2RXH2 1/20 0.44
NPC1 O15118 1/20 0.44
ALDH1A1 P00352 1/20 0.44
RAB9A P51151 1/20 0.44
LTB4R Q15722 1/20 0.43
LTB4R2 Q9NPC1 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
ALOX5 P09917 1/20 0.42
LTA4H P09960 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7989427 1.00 MMP9 (0.51) MMP9MMP8PPARGMAOBMME
SCHEMBL7977831 0.87 MMP2 (0.44) MMP9MMP8PPARGMAOBMME
SCHEMBL7977828 0.87 MMP2 (0.44) MMP9MMP8PPARGMAOBMME
SCHEMBL7975785 0.85 MAOB (0.47) PPARGMAOBKDM4ENPC1ALDH1A1
SCHEMBL7975789 0.85 MAOB (0.47) PPARGMAOBKDM4ENPC1ALDH1A1
SCHEMBL7989433 0.80 KDM4E (0.43) KDM4ENPC1ALDH1A1RAB9ALTB4R
SCHEMBL7986414 0.79 MEN1 (0.40) PPARGNPC1ALDH1A1RAB9AMEN1
SCHEMBL7986417 0.79 MEN1 (0.40) PPARGNPC1ALDH1A1RAB9AMEN1
SCHEMBL7993920 0.76 ALDH1A1 (0.39) ACENPC1ALDH1A1RAB9AMEN1
SCHEMBL7993921 0.76 ALDH1A1 (0.39) ACENPC1ALDH1A1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001040198-A2 MACROCYCLIC HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS ANTIMICROBIAL AGENTS AVENTIS PHARMA S.A. (FR) 2001-06-07 WO disclosed